title: Alternative mechanisms for gene activation induced by poly(rI).poly(rC) and Newcastle disease virus.
abstract: After poly(rI).poly(rC) induction of FS-4 fibroblasts, both human interferon-beta (IFN-beta) mRNA and an additional induced RNA class (12S RNA) hybridize to a genomic cosmid clone containing the human IFN-beta gene as well as 35 kbp of flanking sequences. However, this coinduced 12S RNA does not originate from regions in the neighborhood of the IFN-beta gene, but hybridizes to the genomic cosmid clone via repetitive Alu-family sequences. While IFN-beta mRNA rapidly decays after reaching a maximum 2-4 h after induction, this 12S RNA is stably maintained in the fibroblast cell for more than 16 h. Contrary to IFN-beta mRNA, the level of the 12S RNA is not further elevated by superinduction conditions (cycloheximide treatment) during poly(rI).poly(rC) induction. However, subsequent to treatment with the weaker viral inducer Newcastle disease virus (NDV) both IFN-beta and the 12S RNA transcripts are induced to a higher level in the presence of cycloheximide. Cell-free translation of hybrid-selected 12S RNA leads to detection of an induced protein of 14 kDa. cDNA cloning reveals that the 12S RNA contains part of an Alu-family sequence in the 5'-untranslated region. The 12S RNA is probably not an RNA polymerase III transcript and codes for a protein of 9 kDa (as monitored by in vitro cell-free translation). This discrepancy in molecular mass can be attributed to a retarded migration of the protein in SDS/PAGE.
authors.affiliation: Gesellschaft für Biotechnologische Forschung, Abteilung Genetik, Braunschweig, Federal Republic of Germany.
authors.forename: R
authors.initials: R
authors.lastname: Lammers
authors.forename: G
authors.initials: G
authors.lastname: Gross
authors.forename: U
authors.initials: U
authors.lastname: Mayr
authors.forename: J
authors.initials: J
authors.lastname: Collins
mesh_terms: D000546:Amanitins / Q000494:pharmacology; D001483:Base Sequence; D002460:Cell Line; D003513:Cycloheximide / Q000494:pharmacology; D004247:DNA / Q000032:analysis; D005347:Fibroblasts / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D007370:Interferon Type I / Q000096:biosynthesis / Q000235:genetics*; D007700:Kinetics; D009522:Newcastle disease virus; D011070:Poly I-C / Q000494:pharmacology*; D012319:RNA Polymerase II / Q000037:antagonists & inhibitors; D012333:RNA, Messenger / Q000032:analysis; D014158:Transcription, Genetic / Q000187:drug effects; D015533:Transcriptional Activation
chemical_list: D000546:Amanitins; D007370:Interferon Type I; D012333:RNA, Messenger; D004247:DNA; D003513:Cycloheximide; D012319:RNA Polymerase II; D011070:Poly I-C